No Data
Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Hold Rating
Needham Sticks to Their Hold Rating for Verrica Pharmaceuticals (VRCA)
Express News | Needham Reiterates Hold on Verrica Pharmaceuticalsto Hold
Verrica Pharmaceuticals Analyst Ratings
Verrica Pharmaceuticals Reports Increased Demand for YCANTH With New Single Applicator Configuration Coming in 2025
Express News | Verrica Pharmaceuticals Inc: Seeing Favorable Changes in Demand Dynamics for Ycanth
loading...
loading...